Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis

Steven D. Nathan

Inova Fairfax Hospital, Falls Church, VA

Peter Smith

United Therapeutics, Durham, NC

Chunqin Deng

United Therapeutics, Durham, NC

Maria De Salvo

Centro Médico Dra. De Salvo, Buenos Aires

Wim Wuyts

Universitair Ziekenhuis Leuven, Leuven, Belgium

Juana Pavie-Gallegos

Centro Respiratorio Integral Cenresin, Quillota, Chile

Jin Woo Song

Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea

Mordechai R. Kramer

Rabin Medical Center, Petah Tikva, Israel

Christopher S. King

Inova Fairfax Hospital, Falls Church, VA

John A. Mackintosh

Prince Charles Hospital, Brisbane, QLD, Australia

Daniel Chambers

University of Queensland, Brisbane, Australia

Georgina Viviana Miranda

Centro de Estudios Clínicos, Santiago, Chile

Natalie Breytenbach

United Therapeutics, Durham, NC

Leigh Peterson

United Therapeutics, Durham, NC

Heidi Bell

United Therapeutics, Durham, NC

Kevin R. Flaherty

Michigan Medicine, University of Michigan, Ann Arbor

Juergen Behr

Department of Medicine V, Ludwig-Maximilians-University Munich University Hospital, Munich, Germany

Vincent Cottin

Université Claude Bernard Lyon 1, Lyon, France